JUL 01, 2016 1:07 PM PDT

Stronger Immune Response to Ward Off Tuberculosis

WRITTEN BY: Kara Marker
Autophagy is a natural process that occurs in the body to remove defective proteins, potentially misfolded or aggregated, from the body to make remove for important, intact sources of energy. In search for a new treatment for tuberculosis that bypasses the growing problem of antibiotic resistance, researchers from Linkoping University are thinking of harnessing the power of autophagy, but there are still a few bumps in the road to resolve.
 Credit: Medical News Today
Tuberculosis (TB) is caused by a bacterium, making antibiotics the primary method of treating infections. However, like many other bacteria species, Mycobacterium tuberculosis finds ways to evolve and become resistant to drugs that target its cellular processes. TB most often affects the lungs, but other parts of the body can be attacked as well. Symptoms of TB usually include a bad, persistent cough, chest pain, and coughing up blood and phlegm. Without treatment, TB is deadly.
 
Isoniazid and rifampicin are two common drugs used to treat TB, but many strains of M. tuberculosis are quickly becoming resistant to these two antibiotics. As an alternative, second-line drugs like amikacin and kanamycin can be used to treat TB, unless the strain if extensively drug-resistant (XDR TB). The more resistant M. tuberculosis bacteria become to existing antibiotics, the more toxic and harmful drugs that are effective will become. That is unless, the researchers from Linkoping University can learn to safely use autophagy as a way to kill TB bacteria.
 
The adapted form of autophagy, called stimulated autophagy, can be very dangerous, mainly when a TB patient also has HIV or when the TB infection is in its first stages where the amount of bacterial colonies is low. When used in these instances, stimulated autophagy actually leads to increased multiplication of bacterial colonies within host cells. When stimulated autophagy is approved to be used, it usually exists in the form of inhibiting a mammalian target of rapamycin complex-1 (mTORC1).
 
For now, finding the “sweet spot” of safe stimulated autophagy will work for patients with aggressive TB infections and those without HIV. However, to address the other two groups, scientists will have to pick apart what causes stimulated autophagy to worsen cases of tuberculosis in these patients. “If this is taken into consideration when new medicines are tested, setbacks could be prevented,” said Robert Blomgran, a research fellow in medicinal microbiology at Linkoping University.
 
This study was recently published in the journal Nature Immunology.
 

 
Sources: Linkoping University,  The Journal of Pathology, Centers for Disease Control and Prevention, National Institute of Allergy and Infectious Diseases, Nature Communications
 
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
NOV 27, 2019
Immunology
NOV 27, 2019
Playing "Tag" with the Immune System
Human cells employ an intricate tagging system to manage protein activity in the body. By “tagging” a protein with a certain modification, cell...
JAN 19, 2020
Immunology
JAN 19, 2020
Overactive Immune Gene May Cause Schizophrenia
A windy road links excessive activity of the “C4” gene to the development of schizophrenia. Researchers begin to study C4 activity as part of n...
MAR 02, 2020
Drug Discovery & Development
MAR 02, 2020
DIY Fecal Transplants Improve Symptoms in 82% of People
Fecal transplants (FMT), the process of putting a healthy person’s fecal matter into another person’s colon, has been approved as a procedure t...
MAR 13, 2020
Immunology
MAR 13, 2020
Malaria drug treats lupus and prevents diabetes
A drug commonly used to treat certain types of malaria has been found to have some surprising synergistic effects: having an anti-inflammatory effect on lu...
MAR 19, 2020
Drug Discovery & Development
MAR 19, 2020
Could a 1949 Malaria Drug Treat COVID-19?
In the race to halt the current coronavirus pandemic, scientists, health experts and even Elon Musk are considering chloroquine, a drug that has been used ...
MAR 11, 2020
Neuroscience
MAR 11, 2020
Categories of Memory Work Together to Form Abstract Thought
Indiana University New research from the University of Trento shows how areas of the brain work to recall complex semantic information.  The brain sto...
Loading Comments...